Gene therapy for haemophilia A using Roctavian and lentivirus vector shows promise in treating the rare, hereditary condition ...

FDA advisors said that more data are needed to fully understand if there are broader safety concerns related to use of ...

Recent studies by the CDC are beginning quantify the true burden of Lyme Disease in the U.S. The discrepancy between the ...

Research led by Christian Medical College in Vellore, India, has demonstrated the successful use of lentiviral vectors to ...

Vector genome maps for plasmids used in the AAV triple plasmid transfection assay ... Our products and solutions are based on ...

This article explores the latest techniques and workflows for purification across biopharmaceuticals including vaccines, ...

MEDLEMSNYHET - Approximately 60-70% of infectious diseases are viral, including COVID-19, influenza, MPXV, HIV, and Ebola. These viruses continue to affect human health and socio-economic development.

ATLANTA, GA, USA I December 11, 2024 I Expression Therapeutics, Inc., has presented the results of a Phase 1 clinical trial for its novel lentiviral ...

Results from a small single-center study showed that treatment with a gene therapy involving the use of lentiviral ...

According to a new market research report, ' Viral Vaccines Market Size, Share, Forecast, & Trends Analysis by Form (Liquid, ...

Department of Microbiolog, Immunology, and Biochemistry. University of Tennessee Health Science Center, Memphis, USA ...